Definitive Contract 75F40121C00165

Award Date 9/2/21
Potential Completion Date 9/29/26
Potential Value $1.2M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive contract awarded to CCS Associates, Inc., a woman-owned small business, by the Food and Drug Administration (FDA) for a quality assurance and quality improvement program to review clinical trials supported or funded by the FDA. The contract has a ceiling value of $87,620.95 and a period of performance that ends on March 29, 2019. It is a time and materials contract type. CCS Associates has received numerous federal contracts and grants, including several large indefinite...
This is a delivery order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to CCS Associates, Inc., a woman-owned small business. The $545,690.33 contract is for regulatory activities supporting PCCA and MMAB gene therapy products. The contract has a period of performance through May 20, 2028 and is a labor hours contract type. CCS Associates has previously secured several large Indefinite Delivery Vehicle (IDV) contracts with NCATS, the...
This federal contract award, valued at $2,471,797.88, was issued by the National Heart Lung and Blood Institute (NHLBI) to CCS Associates, Inc., a woman-owned small business. The contract is for research and development related to vascular intervention and therapeutic advances. It is a Cost Plus Fixed Fee contract with a total small business set-aside. CCS Associates has extensive experience supporting federal agencies like the Department of Health and Human Services, National Institutes of...
CCS Associates, Inc. has been awarded a delivery order against their indefinite delivery/indefinite quantity contract by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences. The $242,354.81 order is for the preparation of an Investigational New Drug application to the Food and Drug Administration for a treatment for Jansen's Metaphyseal Chondrodysplasia. Work will be performed in San Jose, California through June 9,...
This is a Definitive Contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to CCS Associates, Inc., a woman-owned small business. The contract, valued at $106,370.26, is for regulatory affairs consulting support services related to the Brain Program Network (BPN) initiative. The contract was awarded as a Total Small Business set-aside on September 4, 2015 and is scheduled for completion on September 13, 2020. CCS Associates has...
This is a firm-fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to CCS Associates, Inc., a woman-owned small business. The $776,157.30 contract supports cancer prevention efforts through information management, regulatory services, and technical support. CCS Associates has secured numerous federal contract and grant awards from NIH institutes and centers,...
This is a $13,284,919.16 cost-plus-fixed-fee contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to CCS Associates, Inc., a woman-owned small business. The contract is for regulatory support services to assist in the development of cancer prevention agents. Key services include information management, regulatory affairs, and technical support. CCS Associates has secured numerous awards from various NIH institutes, including the National...
This is a federal contract award from the Food and Drug Administration (FDA) to Consolidated Safety Services Incorporated (CSS), a small business based in Fairfax, Virginia. The $156,190.17 firm fixed-price contract is for environmental sampling and microbial analysis services under the FDA's Global Environmental Sampling and Analysis 2013-2018 Indefinite Delivery Vehicle (IDV). CSS will provide these services at a place of performance in Fairfax, Virginia. The contract has a total small...
The Department of Health and Human Services Food and Drug Administration awarded a $2.7 million delivery order to Chakrabarti Management Consultancy, Inc. doing business as Cmci. The order is placed against the 8a Streamlined Technology Acquisition Resources for Services II government-wide acquisition contract vehicle. Under the order, Cmci will provide technical capabilities support to the Center for Drug Evaluation and Research including electronic submissions, integrated data management,...
This is a cost-plus-fixed-fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to CCS Associates, Inc., a woman-owned small business. The $179,419.42 contract has an ultimate completion date of April 30, 2024 and is for vendor audit services under a larger, $545 million multiple-award indefinite delivery vehicle (IDV) held by CCS Associates to provide comprehensive research support services to NIAID through 2028. This IDV enables CCS Associates to...

CCS Associates, Inc. was awarded a definitive contract valued at approximately $1.2 million by the Department of Health and Human Services' Food and Drug Administration to provide unspecified tasks and deliverables in Silver Spring, Maryland over a five-year period concluding in September 2026. The firm fixed price contract has a total small business set aside designation. As the prime contractor, CCS Associates will support the FDA, an HHS agency responsible for protecting public health by ensuring the safety and effectiveness of medical products, through the contracted work to be performed at its headquarters location.

Generated 12/25/23, 6:26 AM